Wang L - Search Results

1

A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma.

Zhao H, Zheng M, Wang K, Wang L, He H, Wang M, Shi Y, Huang S, Ji F, Li X, Zhu H, Wang L, Zhang X, Shi X, Zhao S, Fu B, Wu T. Zhao H, et al. Among authors: wang l, wang k, wang m. J Cancer Res Ther. 2018;14(4):807-814. doi: 10.4103/jcrt.JCRT_858_17. J Cancer Res Ther. 2018. PMID: 29970657 Free article.

2

Leptin promotes proliferation and metastasis of human gallbladder cancer through OB-Rb leptin receptor.

Zou H, Liu Y, Wei D, Wang T, Wang K, Huang S, Liu L, Li Y, Ge J, Li X, Zhu H, Wang L, Zhao S, Zhang X, Wang L. Zou H, et al. Among authors: wang l, wang k, wang t. Int J Oncol. 2016 Jul;49(1):197-206. doi: 10.3892/ijo.2016.3530. Epub 2016 May 18. Int J Oncol. 2016. PMID: 27211817

3

Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma.

Kang Q, Zou H, Yang X, Cai JB, Liu LX, Xie N, Wang LM, Li YH, Zhang XW. Kang Q, et al. Oncol Lett. 2018 Feb;15(2):2161-2168. doi: 10.3892/ol.2017.7570. Epub 2017 Dec 8. Oncol Lett. 2018. PMID: 29434920 Free PMC article.

4

Role of the overexpression of TRAF4 in predicting the prognosis of intrahepatic cholangiocarcinoma.

Kang Q, Zou H, Zhou L, Liu LX, Cai JB, Xie N, Li WH, Zhang C, Shi WH, Wang LM, Zhang WH, Zhu H, Wang SF, Zhang XW. Kang Q, et al. Among authors: wang lm, wang sf. Int J Oncol. 2018 Jul;53(1):286-296. doi: 10.3892/ijo.2018.4383. Epub 2018 Apr 26. Int J Oncol. 2018. PMID: 29749456

5

Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients.

Ji F, Kang Q, Wang L, Liu L, Ke Y, Zhu Y, Zhang N, Xiong S, Li Y, Zou H. Ji F, et al. Among authors: wang l. Medicine (Baltimore). 2020 Oct 23;99(43):e22827. doi: 10.1097/MD.0000000000022827. Medicine (Baltimore). 2020. PMID: 33120809 Free PMC article.

6

Local application of triamcinolone acetonide-conjugated chitosan membrane to prevent benign biliary stricture.

Wang T, Zhang S, Wang L, Su K, Tang Z, He H, Shi Y, Liu Y, Zheng M, Fu W, Hu S, Zhang X, Wu T. Wang T, et al. Among authors: wang l. Drug Deliv Transl Res. 2022 Dec;12(12):2895-2906. doi: 10.1007/s13346-022-01153-2. Epub 2022 Apr 14. Drug Deliv Transl Res. 2022. PMID: 35426041

7

HS6ST1 overexpressed in cancer-associated fibroblast and inhibited cholangiocarcinoma progression.

Hu S, Xia C, Zou H, Ren W, Liu L, Wang L, Kang Q, He K, Wang T, Zhang X. Hu S, et al. Among authors: wang l, wang t. Dig Liver Dis. 2023 Aug;55(8):1114-1125. doi: 10.1016/j.dld.2022.12.007. Epub 2022 Dec 29. Dig Liver Dis. 2023. PMID: 36586771

8

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma.

Hu S, Wang X, Wang T, Wang L, Liu L, Ren W, Liu X, Zhang W, Liao W, Liao Z, Zou R, Zhang X. Hu S, et al. Among authors: wang x, wang l, wang t. BMC Med Genomics. 2022 Aug 26;15(1):185. doi: 10.1186/s12920-022-01338-1. BMC Med Genomics. 2022. PMID: 36028818 Free PMC article.

9

Standard: Human gastric organoids.

Hong F, Tan R, Wang T, Zhong N, Zhao H, Xu RH, Shen L, Liu Y, Yao X, Xiang D, Hui L, Xiong J, Gao D, Zhao B, Miao Z, Hao J, Li Y, Hu S, Fu B, Hua G, Wang L, Zeng ZL, Chen C, Wu J, Wang C, Wang C, Zhan X, Song C, Yu C, Yang Y, Niu G, Wang Y, Zhao T, Chen YG. Hong F, et al. Among authors: wang l. Cell Regen. 2025 Jan 14;14(1):2. doi: 10.1186/s13619-024-00218-6. Cell Regen. 2025. PMID: 39808364

10

Targeting CHEK1: Ginsenosides-Rh2 and Cu2O@G-Rh2 nanoparticles in thyroid cancer.

Wang L, Wu X, Wang X, Dong M, Zhang H, Zhao P. Wang L, et al. Cell Biol Toxicol. 2025 Jan 14;41(1):30. doi: 10.1007/s10565-024-09961-7. Cell Biol Toxicol. 2025. PMID: 39808342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,219 results

Search Page

Filters